Thank you for sharing!

Your article was successfully shared with the contacts you provided.

The gap continues to widen between supply and demand in the life sciences sector across the largest US cities, with companies in the space seeking nearly 24 million square feet of new real estate in the third quarter alone.

That figure exceeds the amount of lab space under spec construction, according to new research from CBRE, by nearly 2.8 million sq. ft. And the pace of demand shows no sign of slowing, the firm maintains: even as construction ramps up, demand continues apace, driven in part by the ongoing need for vaccines for COVID-19 and other viruses.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2022 ALM Global, LLC. All Rights Reserved.